Premium
Treatment of an alopecia areata patient with tofacitinib results in regrowth of hair and changes in serum and skin biomarkers
Author(s) -
Jabbari Ali,
Nguyen Nhan,
Cerise Jane E.,
Ulerio Grace,
Jong Annemieke,
Clynes Raphael,
Christiano Angela M.,
MackayWiggan Julian
Publication year - 2016
Publication title -
experimental dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.108
H-Index - 96
eISSN - 1600-0625
pISSN - 0906-6705
DOI - 10.1111/exd.13060
Subject(s) - tofacitinib , alopecia areata , medicine , janus kinase inhibitor , janus kinase , ruxolitinib , dermatology , alopecia universalis , biomarker , hair loss , gastroenterology , pharmacology , rheumatoid arthritis , biology , receptor , myelofibrosis , bone marrow , biochemistry
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom